Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


27.03.2017

1 Am J Hematol
1 Ann Hematol
2 Blood
1 BMC Genomics
1 BMJ
2 Cancer
1 Gene
6 Int J Hematol
1 Leuk Res
4 Leukemia
1 PLoS Comput Biol
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. KANDARPA M, Wu YM, Robinson D, Burke PW, et al
    Clinical Characteristics and Whole Exome/Transcriptome Sequencing of Coexisting Chronic Myeloid Leukemia and Myelofibrosis.
    Am J Hematol. 2017 Mar 23. doi: 10.1002/ajh.24728.
    PubMed     Text format     Abstract available


    Ann Hematol

  2. BOTH A, Krauter J, Damm F, Thol F, et al
    The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia.
    Ann Hematol. 2017 Mar 22. doi: 10.1007/s00277-017-2967.
    PubMed     Text format     Abstract available


    Blood

  3. FISCHER K, Al-Sawaf O, Fink AM, Dixon M, et al
    Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
    Blood. 2017 Mar 21. pii: blood-2017-01-761973. doi: 10.1182/blood-2017-01-761973
    PubMed     Text format    

  4. CHENG CK, Wang AZ, Wong TH, Wan TS, et al
    FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia.
    Blood. 2017 Mar 17. pii: blood-2017-02-767707. doi: 10.1182/blood-2017-02-767707
    PubMed     Text format    


    BMC Genomics

  5. VLAANDEREN J, Leenders M, Chadeau-Hyam M, Portengen L, et al
    Exploring the nature of prediagnostic blood transcriptome markers of chronic lymphocytic leukemia by assessing their overlap with the transcriptome at the clinical stage.
    BMC Genomics. 2017;18:239.
    PubMed     Text format     Abstract available


    BMJ

  6. DYER O
    FDA lifts hold on cancer immunotherapy trial placed after patients died.
    BMJ. 2016;354:i3965.
    PubMed     Text format    


    Cancer

  7. RYTTING ME, Jabbour EJ, O'Brien SM, Kantarjian HM, et al
    Acute lymphoblastic leukemia in adolescents and young adults.
    Cancer. 2017 Mar 22. doi: 10.1002/cncr.30624.
    PubMed     Text format     Abstract available

  8. NAGLER A, Labopin M, Beelen D, Ciceri F, et al
    Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Cancer. 2017 Mar 22. doi: 10.1002/cncr.30646.
    PubMed     Text format     Abstract available


    Gene

  9. JUNGE A, Zandi R, Havgaard JH, Gorodkin J, et al
    Assessing the miRNA sponge potential of RUNX1T1 in t(8;21) acute myeloid leukemia.
    Gene. 2017 Mar 16. pii: S0378-1119(17)30173-7. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    Int J Hematol

  10. MONIKA BELICKOVA M, Merkerova MD, Votavova H, Valka J, et al
    Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms.
    Int J Hematol. 2016;104:566-573.
    PubMed     Text format     Abstract available

  11. RUBIO P, Campos B, Digiorge JA, Gallego MS, et al
    NPM1, FLT3 and CEBPA mutations in pediatric patients with AML from Argentina: incidence and prognostic value.
    Int J Hematol. 2016;104:582-590.
    PubMed     Text format     Abstract available

  12. JUNG KS, Cho SH, Kim SJ, Ko YH, et al
    Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma.
    Int J Hematol. 2016;104:591-595.
    PubMed     Text format     Abstract available

  13. UEMURA M, Imataki O, Kawachi Y, Kawakami K, et al
    Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor.
    Int J Hematol. 2016;104:621-627.
    PubMed     Text format     Abstract available

  14. KATZ BZ, Herishanu Y
    Fragility of sub-cellular structures in chronic lymphocytic leukemia.
    Int J Hematol. 2017 Mar 21. doi: 10.1007/s12185-017-2218.
    PubMed     Text format    

  15. BARAKA A, Sherief LM, Kamal NM, Shorbagy SE, et al
    Detection of minimal residual disease in childhood B-acute lymphoblastic leukemia by 4-color flowcytometry.
    Int J Hematol. 2017 Mar 21. doi: 10.1007/s12185-017-2206.
    PubMed     Text format     Abstract available


    Leuk Res

  16. GARCIA C, Rosen A, Kimby E, Aguilar-Santelises M, et al
    Erratum to "Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS)" [Leukemia Res. 13(1) (1989) 31-37].
    Leuk Res. 2017 Mar 14. pii: S0145-2126(17)30041.
    PubMed     Text format    


    Leukemia

  17. POZZO F, Bittolo T, Vendramini E, Bomben R, et al
    NOTCH1 mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin-1 and ribosome associated components.
    Leukemia. 2017 Mar 21. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  18. EISFELD AK, Mrozek K, Kohlschmidt J, Nicolet D, et al
    The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.
    Leukemia. 2017 Mar 21. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  19. ZHOU H, Mak PY, Mu H, Mak DH, et al
    Combined inhibition of beta-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo.
    Leukemia. 2017 Mar 21. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  20. KAYSER S, Krzykalla J, Elliott MA, Norsworthy K, et al
    Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.
    Leukemia. 2017 Mar 21. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  21. GRECHKIN M, Logsdon BA, Gentles AJ, Lee SI, et al
    Identifying Network Perturbation in Cancer.
    PLoS Comput Biol. 2016;12:e1004888.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  22. FABBRI G, Holmes AB, Viganotti M, Scuoppo C, et al
    Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia.
    Proc Natl Acad Sci U S A. 2017 Mar 17. pii: 201702564.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: